Acta Scientific Women's Health (ASWH)(ISSN: 2582-3205)

Research Article Volume 2 Issue 11

Prevalence of TORCH Infections during Pregnancy: A Prospective Cohort Study in Tribal Region of Gujarat, India

Kranti Suresh Vora1,2*, Paridhi Gupta1, Shahin Saiyed1, Bhumika Prajapati1 and Senthilkumar Natesan1

1Indian Institute of Public Health Gandhinagar (IIPHG), Gujarat, India
2University of Canberra, Australia

*Corresponding Author: Kranti Suresh Vora, Additional Professor, IIPHG, Visiting Fellow, University of Canberra, Australia.

Received: September 17, 2020; Published: October 08, 2020



Introduction: Maternal infections are important causes of poor birth outcomes, child morbidity, and mortality. The most common infections during pregnancy causing adverse birth outcomes are TORCH. Few studies have been done in India to know prevalence of TORCH in general population. The objective of this study is to determine the Prevalence of TORCH infections in a tribal area of the Aravalli district in Gujarat, India.

Methods: Pregnant women in any gestational age residing in tribal area were eligible for this study. The maternal blood sample were collected once during pregnancy to study TORCH infections through molecular detection by nested-PCR and IgG-IgM antibodies detection through ELISA method.

Results: At the time of the study women who were pregnant (n = 901) were included in this research. Prevalence of toxoplasmosis, CMV, and HSV was reported to be 39%, 37%, and 38% respectively. ELISA IgM positivity for toxoplasmosis was 1.22%, CMV was 2.7%, HSV was 4%, and Rubella was 1.55%.

Conclusion: High prevalence of TORCH infections in tribal community by DNA detection indicates higher vulnerability of this population. Regular screening during antenatal period should be done to prevent poor pregnancy outcomes in women.

Keywords: Pregnancy; Prevalence; TORCH; Tribal Women; India; Poor Birth Outcomes; Maternal Infections



  1. Kumari N., et al. "Is screening of TORCH worthwhile in women with bad obstetric history: An observation from Eastern Nepal". Journal of Health Population Nutrition1 (2011): 77-80.
  2. Leung KKY., et al. "Congenital infections in Hong Kong: an overview of TORCH". Hong Kong Medical Journal2 (2020): 127-138.
  3. Padmavathy M., et al. "Seroprevalence of TORCH Infections and Adverse Reproductive Outcome in Current Pregnancy with Bad Obstetric History". Journal of Clinical and Biomedical Sciences2 (2013): 61-71.
  4. Yadav RK., et al. "A review on TORCH: groups of congenital infection during pregnancy". Journal of Scientific and Innovative Research 2 (2014): 258-264.
  5. Sen MR., et al. "Prevalence of serum antibodies to TORCH infection in and around Varanasi, North India". Journal of Clinical and Diagnostic Research9 (2012): 1483-1485.
  6. Turbadkar D., et al. "Seroprevalence of TORCH infection in bad obstetric history". Indian Journal of Medical Microbiology2 (2003): 108-110.
  7. Chung MH., et al. "TORCH (Toxoplasmosis, rubella, cytomegalovirus, and herpes simplex virus) screening of small for gestational age and intrauterine growth restricted neonates: Efficacy study in a single institute in Korea". Korean Journal of Pediatrics4 (2018): 114-120.
  8. Sahu SK., et al. "Seroprevalence of TORCH infection among pregnant women". International Journal of Community Medicine and Public Health5 (2019): 2189.
  9. Surpam RB., et al. "Serological study for TORCH infections in women with bad obstetric history". Journal of Obstetrics and Gynecology of India. 56.1 (2006): 41-43.
  10. Batra P., et al. "Epidemiology of TORCH Infections and Understanding the Serology in Their Diagnosis". Journal of Fetal Medicine1 (2020): 25-29.
  11. Espiritu MM., et al. "Utility of routine urine CMV PCR and total serum IgM testing of small for gestational age infants: A single center review". Journal of Perinatal Medicine1 (2018): 81-86.
  12. Rajani M. "Serological profile of TORCH infection among antenatal women at a tertiary care center in North India". Journal of Pure and Applied Microbiology 4 (2018): 2305-2311.
  13. Government of India. "Census of India 2011" (2020).
  14. Pandey VK., et al. "Modified BG prasad socio-economic classification, update - 2019". Indian Journal of Community Health1 (2019): 123-125.
  15. Zhang S., et al. "Monitoring human cytomegalovirus infection with nested PCR: Comparison of positive rates in plasma and leukocytes and with quantitative PCR". Virology Journal 7 (2010): 1-7.
  16. Wanger A., et al. "Overview of Molecular Diagnostics Principles". Microbiology and Molecular Diagnosis in Pathology (2017): 233-257.
  17. Carr J., et al. "Molecular Detection of Multiple Respiratory Viruses". Molecular Diagnostics (2010): 289-300.
  18. Vora K., et al. "A community-based prospective cohort study of pregnant women in tribal Gujarat- A methodology". Indian Journal of Obstetrics and Gynecology Research2 (2020): 160-164.
  19. Singh L., et al. "Seroprevalence of TORCH infections in antenatal and HIV positive patient populations". Medical Journal Armed Forces India2 (2015): 135-138.
  20. Golalipour MJ., et al. "Possible role of TORCH agents in congenital malformations in Gorgan, northern Islamic Republic of Iran". Eastern Mediterranean Health Journal2 (2009): 330-336.
  21. De Carolis S., et al. "Association between false-positive TORCH and antiphospholipid antibodies in healthy pregnant women". Lupus5 (2018): 841-846.
  22. Mahmood SH., et al. "Detection of B1 gene of Toxoplasma gondii in blood of pregnant and abortive women infected with this parasite". Iraqi Journal of Medical Sciences 3 (2010): 42-48.
  23. Karad D., et al. "Seroprevalence of Torch Infections in Bad Obstetrics History in HIV and Non-HIV Women in Solapur District of Maharashtra India". Journal of Human Virology and Retrovirology 7 (2015): 00067.
  24. Gollub EL., et al. "Effectiveness of health education on Toxoplasma-related knowledge, behaviour, and risk of seroconversion in pregnancy". European Journal of Obstetrics and Gynecology and Reproductive Biology 2 (2008): 137-145.
  25. Kravetz J. "Congenital toxoplasmosis". BMJ Clinical Evidence (2013): 0906
  26. Prasoona KR., et al. "Seroprevalence and Influence of Torch Infections in High Risk Pregnant Women: A Large Study from South India". Journal of Obstetrics and Gynecology of India 5 (2015): 301-319.
  27. Shrivastava G., et al. "Seroprevalance of toxoplasma, rubella, CMV and HSV infection in pregnant women in central India". International Journal of Health System and Disaster Management 3 (2014): 166.
  28. Tiwari S., et al. "TORCH IgM seroprevalence in women with abortions as adverse reproductive outcome in current pregnancy". International Journal of Research in Medical Sciences3 (2016): 784-788.
  29. Chen L., et al. "Seasonal influence on TORCH infection and analysis of multi-positive samples with indirect immunofluorescence assay". Journal of Clinical Laboratory Analysis4 (2019): 1-6.
  30. Janak K., et al. "Adverse reproductive outcome induced by Parvovirus B19 and TORCH infections in women with high-risk pregnancy". Journal of Infection in Developing Countries 12 (2011): 868-873.
  31. Sharma S., et al. "Seroprevalence of Toxoplasma , Rubella and CMV infections in Antenatal Women in a Tertiary care hospital in North India". Journal of Communicable Diseases2 (2015): 23-26.
  32. Cannon MJ., et al. "Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection". Reviews in medical virology 20 (2010): 202-213.
  33. Thayyil J., et al. "Prevalence of rubella-specific IgG antibodies in unimmunized young female population". Journal of Family Medicine and Primary Care 3 (2016): 658.
  34. Lakshmikumar MT., et al. "Prevalence of Transfusion Transmitted Infections among Blood Donors : Five Years Retrospective Study from Rural Tertiary Care Hospital of South Karnataka". Galore International Journal of Health Sciences and Research3 (2019): 113-115.
  35. Chandra T., et al. "Decreasing prevalence of transfusion transmitted infection in Indian scenario". The Scientific World Journal (2014): 4.
  36. Chaurasia R., et al. "Screening Donated Blood for Transfusion Transmitted Infections by Serology along with NAT and Response Rate to Notification of Reactive Results: An Indian Experience". Journal of Blood Transfusion (2014): 1-6.
  37. Sawke N., et al. "Seroprevalence Of Common Transfusion - Transmitted Blood Donors". People’s Journal of Scientific Research1 (2010): 5-7.
  38. Franco E., et al. "Hepatitis B: Epidemiology and prevention in developing countries". World Journal of Hepatology 3 (2012): 74-80.
  39. Eke AC., et al. "Prevalence, correlates and pattern of hepatitis B surface antigen in a low resource setting". Virology Journal1 (2011): 12.


Citation: Kranti Suresh Vora., et al. “Prevalence of TORCH Infections during Pregnancy: A Prospective Cohort Study in Tribal Region of Gujarat, India". Acta Scientific Women's Health 2.11 (2020): 16-22.


Acceptance rate35%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US